Agilent (NYSE: A) director receives 2,158-share stock award, defers receipt

Rhea-AI Filing Summary

Podolsky Daniel K reported acquisition or exercise transactions in this Form 4 filing.

Agilent Technologies director Daniel K. Podolsky received a grant of 2,158 shares of common stock valued at $111.75 per share. The award was made as compensation for non-employee directors and is fully vested upon grant. Podolsky elected to defer receipt of these shares, meaning delivery is postponed under Agilent’s deferral arrangements.

Following this award and prior dividend reinvestment activity noted in the footnotes, Podolsky now holds 38,179.908 shares of Agilent common stock in total.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Podolsky Daniel K

(Last) (First) (Middle)

5301 STEVENS CREEK BLVD

(Street)

SANTA CLARA CALIFORNIA 95051

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AGILENT TECHNOLOGIES, INC. [ A ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/19/2026		A		2,158	A	$111.75(1)	38,179.908(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired from award of Agilent Technologies, Inc. common stock for Non-Employee Directors that are fully vested upon grant. The reporting person has elected to defer receipt of these shares of common stock.

2. 285.092 shares were acquired through the Agilent Technologies, Inc. dividend reinvestment plan. The reporting person has elected to defer these shares of common stock.

Remarks:

See Exhibit 24 - Power of Attorney

	/s/ Shirley Qin, attorney-in-fact for Dr. Podolsky	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Agilent (A) director Daniel K. Podolsky report in this Form 4?

Daniel K. Podolsky reported receiving 2,158 shares of Agilent common stock as a fully vested director award. The shares were valued at $111.75 each, and he chose to defer receipt under Agilent’s deferral program rather than take immediate delivery.

Was the Agilent (A) Form 4 transaction an open-market stock purchase or sale?

The Form 4 transaction was not an open-market trade; it was a grant of 2,158 fully vested shares as director compensation. The filing shows no buys or sells, only an acquisition classified as a grant or award of common stock to the non-employee director.

How many Agilent (A) shares does Daniel K. Podolsky hold after this reported grant?

After the reported grant, Daniel K. Podolsky holds 38,179.908 shares of Agilent common stock. This total reflects the newly granted 2,158 shares plus previously accumulated holdings, including shares acquired through Agilent’s dividend reinvestment plan as described in the footnotes.

What does it mean that Agilent (A) director Podolsky deferred receipt of the granted shares?

Deferring receipt means Podolsky has postponed taking delivery of the 2,158 granted shares under Agilent’s deferral arrangements. The award is fully vested, but actual share distribution occurs later according to the deferral terms, which can affect timing of income recognition and ownership transfer.

What is the significance of the dividend reinvestment plan mentioned in the Agilent (A) Form 4 footnotes?

The footnotes state that 285.092 shares were acquired through Agilent’s dividend reinvestment plan and also deferred. This indicates additional shares accumulated automatically from reinvested dividends, contributing to Podolsky’s total holdings while similarly being subject to deferred receipt elections.